Literature DB >> 16844322

Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.

Jae Hyung Park1, Jung Min Park, Eun Jin Kim, Sung Ick Cha, Eung Bae Lee, Chang Ho Kim, Sin Kam, Tae Hoon Jung, Jae Yong Park.   

Abstract

BACKGROUND: Myeloperoxidase (MPO) contributes to pulmonary carcinogenesis through activation of a wide range of tobacco smoke procarcinogens, including benzo[a]pyrene and aromatic amines. A -463G>A polymorphism in the promoter region of the MPO gene has been shown to reduce MPO expression and activity. It is therefore possible that carriers of the -463A allele may be at decreased risk of lung cancer. To test this hypothesis we have investigated the association between the -463G>A polymorphism of MPO gene and the risk of lung cancer in a Korean population.
METHODS: The MPO genotype was determined in 432 lung cancer patients and 432 healthy controls that were frequency-matched for age and gender.
RESULTS: In the current study, the risk estimate for lung cancer of the combined -463 AA+GA genotype was not significantly different from that of the -463GG genotype (adjusted OR=1.03, 95% CI=0.72-1.47). In addition, we observed no evidence of effect modification by age, gender, smoking history or tumor histology.
CONCLUSIONS: These results suggest that the MPO -463G>A polymorphism does not significantly affect the susceptibility to lung cancer in Koreans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844322     DOI: 10.1016/j.cdp.2006.04.002

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  11 in total

1.  Myeloperoxidase G463A polymorphism and lung cancer risk in Asians: a pooled analysis.

Authors:  Yi-yong Zhou; Shao-ming Zhang; Zhi-gang Cai; Heng Zhang; Lei Wang; Xiao-ping Xu; Hai-bo Wu
Journal:  Tumour Biol       Date:  2013-07-07

2.  APE1 Asp148Glu polymorphism and lung cancer susceptibility.

Authors:  Liyun Cai; Yingjv Fu; Yuanyue Zhang
Journal:  Tumour Biol       Date:  2014-02-13

Review 3.  Genetic susceptibility to lung cancer--light at the end of the tunnel?

Authors:  Ariela L Marshall; David C Christiani
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

4.  Association of myeloperoxidase with ovarian cancer.

Authors:  Dan Cacsire Castillo-Tong; Dietmar Pils; Georg Heinze; Ioana Braicu; Jalid Sehouli; Alexander Reinthaller; Eva Schuster; Andrea Wolf; Rafal Watrowski; Richard A Maki; Robert Zeillinger; Wanda F Reynolds
Journal:  Tumour Biol       Date:  2013-07-27

5.  Association between myeloperoxidase G-463A polymorphism and lung cancer risk.

Authors:  Chao Huang; Lu Ma; Dejia Li
Journal:  Tumour Biol       Date:  2013-08-14

6.  Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.

Authors:  Chengzhi Zhou; Qun Luo; Yinyin Qing; Xinqing Lin; Yangqin Zhan; Ming Ouyang
Journal:  Tumour Biol       Date:  2013-08-14

7.  Myeloperoxidase G463A polymorphism and risk of lung cancer.

Authors:  Junrui Li; Yingju Fu; Baochun Zhao; Ying Xiao; Ruiying Chen
Journal:  Tumour Biol       Date:  2013-08-25

8.  The MPO-463G>A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies.

Authors:  Jun-Ping Yang; Wen-Bo Wang; Xiao-Xi Yang; Lei Yang; Li Ren; Fu-Xiang Zhou; Liu Hu; Wei He; Bai-Yu Li; Yan Zhu; Huan-Gang Jiang; Yun-Feng Zhou
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  Glutathione S-transferase T1 and myeloperoxidase -463 G>A genotypes in lung cancer patients of Kumaun region.

Authors:  Arundhati Bag; Niladri Bag; Lalit Mohan Jeena; Narayan Singh Jyala
Journal:  J Nat Sci Biol Med       Date:  2014-07

Review 10.  Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.

Authors:  Wen-Jun Yang; Ming-Yue Wang; Fu-Ze Pan; Chen Shi; Hong Cen
Journal:  World J Surg Oncol       Date:  2017-08-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.